RxDoctor Payments DataLook up a doctor →

Mitchell Efros, MD

Urology · Garden City, NYNPI 1205892163

Payments from drug & device makers

$4,199,497in general payments, 2019–2025

Across 863 payments — averaging $4866.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Upsher-smith Laboratories LLC$1.1M
  • AbbVie$897K
  • IBSA Institut Biochimique SA$740K
  • Endo Pharmaceuticals Inc.$410K
  • Urovant Sciences Inc$202K
  • Tolmar, Inc.$169K
  • plus $714K from 45 others
$51,282in research payments, 2019–2025

Across 3 payments — averaging $17,094 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Seikagaku Corporation$51K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Upsher-smith Laboratories LLC20$1,068,743
AbbVie(2 entities)174$897,097
IBSA Institut Biochimique SA14$739,645
Endo Pharmaceuticals Inc.51$409,557
Urovant Sciences Inc59$201,574
Tolmar, Inc.28$169,160
Sumitomo Pharma America, Inc.40$152,724
Urogen Pharma, Inc.101$118,505
Ironwood Pharmaceuticals, Inc25$94,694
OPKO Pharmaceuticals, LLC7$86,984
Acerus Pharmaceuticals Corporation15$69,152
Alnylam Pharmaceuticals Inc.43$61,802
Ferring Pharmaceuticals AS2$35,250
Myovant Sciences Inc.21$28,071
Astellas Pharma Global Development16$18,980
Pfizer38$15,423
Janssen Research & Development, LLC8$12,744
Laborie Medical Technologies Corp.7$7,624
Ferring International Pharmascience Center US1$2,917
Urotronic, Inc1$2,566
Shionogi Inc2$1,130
Astellas Pharma US Inc55$1,098
Merck4$1,041
Johnson & Johnson42$694
Procept Biorobotics Corporation6$286
Neotract Inc.7$216
Cook Medical LLC1$195
Axonics, Inc.3$183
Teleflex LLC9$171
Coloplast11$167
Myriad Genetic Laboratories, Inc.7$136
Progenics Pharmaceuticals, Inc.5$125
Antares Pharma, Inc.6$115
Tolmar Pharmaceuticals, Inc.5$93
Dendreon Pharmaceuticals LLC3$73
EMD Serono, Inc.3$71
Bayer3$66
Blue Earth Diagnostics3$56
Hollister Incorporated3$49
GE HealthCare1$44
Palette Life Sciences, Inc.1$43
Amgen2$43
Olympus America Inc.2$36
Civco Medical Instruments1$25
Boston Scientific1$24
Accord Healthcare, Inc.1$22
Dentsply IH Inc.1$20
Avadel Specialty Pharmaceuticals, LLC1$18
ABC Home Medical Supply, Inc.1$16
Mission Pharmacal Company1$15
Mylan Institutional Inc.1$15

How this compares

$4,199,497 in reported general payments places this provider in the 95th percentile of 952 urology providers in New York.

See all urology providers in New York →

Medicare billing

Part B allowed, 2024
$511,419
Medicare patients
1,023
Services billed
11,856

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other urology in Garden City

See the full list for New York →

Where these figures come from

Is this you, or does something look wrong? →